We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Viewpoint | 
Meredith Y. Smith, PhD, MPA; Paul J. Seligman, MD, MPH
JAMA. 2015;314(17):1793-1794. doi:10.1001/jama.2015.11871.

Editorial | 
Joshua M. Sharfstein, MD; Aaron S. Kesselheim, MD, JD, MPH
JAMA. 2015;314(3):233-234. doi:10.1001/jama.2015.7151.

Editorial | 
Phil B. Fontanarosa, MD, MBA; Howard Bauchner, MD; Robert M. Golub, MD
JAMA. 2015;314(3):235-236. doi:10.1001/jama.2015.8232.

News From the Centers for Disease Control and Prevention | 
Anita Slomski, MA
JAMA. 2015;314(2):116. doi:10.1001/jama.2015.7236.

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2015;314(1):17. doi:10.1001/jama.2015.7109.

News From the Food and Drug Administration | 
Rita Rubin, MA
JAMA. 2015;313(17):1704. doi:10.1001/jama.2015.4114.

Editorial | 
Charles L. Campbell, MD; David J. Moliterno, MD
JAMA. 2015;313(8):801-802. doi:10.1001/jama.2015.0567.

Original Investigation |  FREE
Anne-Marie Schjerning Olsen, MD, PhD; Gunnar H. Gislason, MD, PhD; Patricia McGettigan, MD; et al.
JAMA. 2015;313(8):805-814. doi:10.1001/jama.2015.0809.
Includes: Supplemental Content

Original Investigation |  FREE
Barthelemy Diouf, PharmD, PhD; Kristine R. Crews, PharmD; Glen Lew, MD; et al.
JAMA. 2015;313(8):815-823. doi:10.1001/jama.2015.0894.
Includes: Supplemental Content

Viewpoint | 
Marc B. Garnick, MD
JAMA. 2015;313(6):563-564. doi:10.1001/jama.2014.17334.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Dose Escalation in Stage III Non–Small-Cell Lung Cancer Patients Agree With the Clinical Results
David Cella, PhD
JAMA Oncology
Research Letter  | 
Consensus on the Existence of Functional Erythropoietin Receptors on Cancer Cells
Charles L. Bennett, MD, PhD, MPP; Stephen Y. Lai, MD, PhD; Oliver Sartor, MD; et al.
JAMA Internal Medicine
Research Letter  | 
Recurrence and Mortality in Young Women With Myocardial Infarction or Ischemic Stroke Long-term Follow-up of the Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) Study
Alberto Maino, MD; Bob Siegerink, PhD; Ale Algra, MD, PhD; et al.
JAMA Dermatology
Observation  | 
Safe Use of Therapeutic-Dose Oral Isotretinoin in Patients With a History of Pseudotumor Cerebri
Suzanne J. Tintle, MD, MPH; Julie C. Harper, MD; Guy F. Webster, MD, PhD; et al.